SAN FRANCISCO, April 22, 2025 — GreenFi launches today, introducing a new brand for climate-friendly banking and investing for consumers. This launch marks the next milestone in restructuring the former Aspiration consumer finance business following last year’s asset buyout. Tim Newell, Founder and CEO of GreenFi, also announced the funding of a $17 million seed investment round in the company.

GreenFi emerged from the 2024 acquisition of Aspiration’s consumer fintech brand by Mission Financial Partners (MFP), led by Newell, the former head of the consumer fintech division at Aspiration and former leader of Tesla’s financial products team. This spin-out established GreenFi as a new independent company dedicated to providing climate-friendly financial solutions. The $17 million investment will accelerate GreenFi’s development of new banking, credit, and investment products that deliver both strong financial value and sustainability.

“We’re proud to launch GreenFi, a brand that demonstrates you can prioritize both your financial well-being and the planet,” said Newell. “GreenFi offers our customers an easy way to align their financial goals with their values, knowing their money is supporting a healthier environment.

The transition to GreenFi will be seamless for existing customers. Accounts will automatically transfer from Aspiration to GreenFi with no disruption. Checking, savings, and investment accounts will remain intact, and all deposits will continue to be free from fossil fuel funding. Customers will continue to make a positive environmental impact with every transaction.

“All of us have the power to make a real difference right now, despite what we see happening in the world, by simply choosing where to bank,” added Newell. “Every dollar spent, invested, or saved with GreenFi is a choice that helps build a sustainable future. Last year alone, our customers funded the planting of more than 4.3 million trees – that’s a tree every 7.3 seconds, or enough trees to reforest more than two and a half football fields a day.”

In the coming months, GreenFi plans to introduce enhanced financial products, including higher-yield savings accounts, climate-friendly credit cards, additional impact investments, and green loans.

About GreenFi

GreenFi (formerly Aspiration) is a leading climate-friendly banking and investing brand, empowering customers to align their financial goals with their values. GreenFi offers a range of sustainable financial products, including checking, savings, and green investment accounts. By integrating climate-friendly choices into everyday banking, GreenFi aims to create a sustainable future for those who want to invest both in their financial well-being and the planet. GreenFi is a financial technology company, not an FDIC-insured bank. Banking Services provided by Coastal Community Bank, Member FDIC. Visit greenfi.com to learn more.

Media Contact
Jenny Beres
Pink Shark PR
941-993-7222
[email protected] 

Contact for Tim Newell
Tim Newell
Founder and CEO, GreenFi
[email protected] 

SOURCE GreenFi

SAN FRANCISCO, April 22, 2025 — SKY Leasing LLC (“SKY Leasing” or “SKY”), a leading alternative investment manager with extensive experience in aviation investments, is proud to announce the final close of its flagship fund, SKY Fund VI, L.P. (together with its parallel fund, “SFVI” or the Fund”). The Fund closed significantly above its target with over $1.35 billion in capital commitments, reflecting strong support from both existing and new investors, including global insurance companies, sovereigns, pension funds, endowments, foundations, and family offices. 

SKY Leasing’s specialized expertise, long-standing relationships, and multi-decade track record in the aviation sector have been pivotal in attracting significant investor interest. The Fund continues SKY Leasing’s successful investment program, focusing on providing innovative capital solutions to airlines primarily through the sale-leaseback of new and current technology aircraft.

“The capital raised for SFVI is a testament to the strong institutional investor demand for SKY’s unique approach to origination and portfolio construction. Our global airline partners increasingly seek capital to transition their fleets from current to new technology aircraft,” said Austin Wiley, Chief Executive Officer of SKY Leasing.

To date, SFVI has committed over $600M of capital to acquire a fleet of 62 aircraft. SFVI, and its predecessor flagship funds, have been consistent in focusing on opportunities that generate attractive risk adjusted returns with strategically important airlines across the globe. This seasoned approach enables SKY Leasing to act as a key partner to aviation industry participants, creating value in complex situations.

Eaton Partners acted as the exclusive global placement agent for the Fund and Kirkland & Ellis LP acted as legal counsel for the Fund.

About SKY Leasing

SKY is an alternative investment manager dedicated to providing asset-focused capital solutions to airlines globally. With a global presence across five offices in San Francisco, Dublin, New York, Miami, and Singapore, SKY leverages a 30-year history of global aviation relationships, technical asset management expertise, and a disciplined investment framework, to originate unique investment opportunities with an emphasis on seeking downside protection and stable cash flow. The company’s fund management business was founded in 2019 with a minority investment from M&G Investments. As of March 2025, the company manages over $5 billion of aviation assets. For more information about SKY Leasing, visit www.skyleasing.com.

Media Contact:
Anne Marie Scaramuzza
[email protected] 

SOURCE SKY Leasing

SAN DIEGO, April 22, 2025 — Trust & Will, the industry leader in digital estate planning, today announced a $4.5 million investment from Curql. The investment is part of Trust & Will’s Series C round and reinforces the company’s commitment to expanding access to estate planning for credit union members nationwide. With this addition, Trust & Will’s total Series C funding will exceed $32 million.

As an innovator in the financial services space, Trust & Will has helped more than one million Americans begin their legacy planning journey, and this strategic investment will enable even greater integration within the credit union ecosystem.

Trust & Will’s collaboration with credit unions began in 2018, evolving from a single partnership to working with more than 200 credit unions today. With this investment, the company is taking its commitment a step further by forming a Credit Union Service Organization (CUSO) – a structure widely embraced within the Curql ecosystem. Through this CUSO, credit unions will have the opportunity to invest in and offer specialized estate planning services tailored to their members’ unique financial wellness needs.  

“Forming a CUSO isn’t just a step forward – it’s a signal of deep commitment to the credit union movement. Trust & Will understands how credit unions operate, and this move brings estate planning even closer to the core of member service,” said Nick Evens, President & CEO of Curql. “We’re proud to back a fintech that’s not only delivering innovation, but doing it the credit union way,”

Curql, a collaborative ecosystem of over 130 credit unions jointly investing in fintech, which exists to bring emerging fintech to credit unions, saw an immediate opportunity in Trust & Will’s mission. The investment aligns with Curql’s focus on transforming financial services for credit unions and their members by ensuring they have access to the next generation of financial tools and technology.  

“Credit unions have long been champions of financial security, helping members build and protect their wealth through every stage of life,” said Cody Barbo, CEO & Co-Founder of Trust & Will. “Estate planning is a natural extension of that mission; providing families with the protection and peace of mind they deserve. From our first credit union partnership to now forming a CUSO, we’ve witnessed the trust and care credit unions bring to their communities. With Curql’s support, we’re making it easier than ever for credit union members to secure their legacies and strengthen their financial futures.”

As part of this next phase of growth, Trust & Will is also joining the National Association of Credit Union Service Organizations (NACUSO) as a Platinum Partner, underscoring its deep integration within the credit union industry. Membership in NACUSO will provide Trust & Will with access to exclusive industry insights, collaborative networking opportunities, and strategic partnerships that will accelerate its impact on credit unions nationwide.  

The investment from Curql and Trust & Will’s expanded role in the credit union industry will ensure that estate planning becomes a seamless part of comprehensive financial wellness strategies for credit union members.

The investment and CUSO formation also resonate across the credit union movement, from large institutions to local, community-driven organizations that prioritize personalized service. For many credit unions, estate planning aligns with their mission of empowering members with financial security, but traditional options often feel out of reach due to complexity and cost.

By leveraging this investment from Curql, Trust & Will is ensuring that credit union members have access to estate planning solutions designed with their needs in mind. Through deepened industry collaboration, financial innovation, and strategic expansion, Trust & Will continues to set the standard for modern estate planning.  

About Trust & Will   
Founded in 2017, Trust & Will is the leading digital estate planning platform in the U.S., trusted by over one million individuals and families. Our simple, secure, and attorney-approved online solutions help Americans easily create wills, trusts, healthcare directives, and other essential estate planning documents tailored to state-specific laws. With a focus on easy access and a guided experience, we’re transforming how families plan for the future and protect their legacies.

Our platform supports 17,000+ financial advisors, along with 150+ enterprise partners and financial institutions, including AARP, Fifth Third Bank, LPL Financial, UBS, and USAA. We empower professionals to integrate estate planning into their client services, enabling multi-generational wealth planning. With more than one million users and $100+ billion in self-reported estate assets, Trust & Will is redefining estate planning as a relationship-deepening driver of financial wellness.

Recognized for innovation and leadership, Trust & Will has earned spots on the CNBC Disruptor 50, Inc. 5000, and Deloitte Technology Fast 500™ lists. Learn more at trustandwill.com.

About Curql
Curql, a collective of over 130 credit unions jointly investing in fintech, brings timely solutions to the credit union industry. With over 40 fintech partners in their Portfolio, Curql ensures that technology is designed specifically for credit unions, allowing them to better serve their members and remain competitive in an evolving financial landscape. Learn more at curql.com. 

SOURCE Trust & Will

Backed by FXP Ventures and SYN Ventures, Terra introduces the first agentic AI pen testing platform with human supervision, while its multi-agent approach leverages dozens of dedicated fine-tuned AI agents to conduct continuous, deep testing at scale

NEW YORK and TEL AVIV, Israel, April 22, 2025 — Terra Security, an Agentic AI-native penetration testing service-as-software platform, raises $8M in a seed round led by SYN Ventures and FXP Ventures with participation from Underscore VC and notable angel investors including former Google CISO Gerhard Eschelback and Ofer Ben-Noon and Ohad Bobrov, founders of Talon Security, Travis McPeak and Itamar Friedman. Already serving multiple clients, including Fortune 500 companies, Terra will use the funds to advance its platform, expand its AI agents’ capabilities, and grow its customer base.

In sports, there’s a saying that the “best defense is a great offense,” and in cybersecurity, this sentiment also holds weight. Yet, most organizations struggle to conduct continuous penetration testing or red teaming – vital simulations that uncover vulnerabilities before attackers exploit them. Despite their promising potential, these ethical hacking mechanisms are vastly underutilized due to their human-intensive nature, which makes them slow, expensive, and unscalable.

Designed to think like a white hat hacker, Terra’s agentic AI platform conducts continuous web application pen testing. Powered by dozens of fine-tuned AI agents, each tailored to a client’s unique environment, Terra’s agents adapt in real time based on unique business contexts and risks. When new vulnerabilities surface, its agents autonomously launch precise tests, guided by human experts through a human-in-the-loop mechanism for maximum accuracy and reliability with AI.

While existing automated solutions fall short of mimicking an adversary’s behavior at scale, particularly for web applications, Terra’s AI-enabled service brings the combination of the accuracy and depth of skilled human testers with the scale and efficiency of automated solutions. As Terra grows, it plans to introduce an agentic AI red teaming solution to its platform as well as expand to cover organizations’ entire network security.

“In the grand scheme of cybersecurity, ethical hacking has long been underutilized due to its inefficiencies and human dependencies, but we now have the opportunity to bring ethical hacking center stage and beat adversaries at their own arena,” says Shahar Peled, CEO and Co-Founder of Terra. “We strongly believe that our platform will transform the narrative around pen testing and ethical hacking by infusing accuracy, efficiency, business context, and continuous pen testing via agentic AI. No longer will pen-testing simply be viewed as an item on a compliance checklist, but as the most effective security capability of a robust security posture. We are grateful for all the support and guidance we’ve received from our investors, partners, and customers, and look forward to the journey ahead.”

“We are thrilled to partner with Terra Security as it works to enable all organizations to leverage high-quality offensive security on a continuous basis, at scale,” says Jay Leek, Managing Partner and Founder at SYN Ventures. “We believe the Company’s vision reimagines penetration testing as we know it today, which is long overdue.”

“Cyber threats move fast and manual pen testing can’t keep up,” says Tsahy Shapsa, Co-Founder and Managing Partner at FXP. “We backed Terra Security from day one because of its founders – an exceptional team with the rare mix of deep technical chops and relentless execution. Together, we validated the problem and approach through over 100 customer interactions to arrive at our conviction. They’re not just improving penetration testing; they’re redefining it with AI employees who work 24/7, guided by top-tier human expertise. It’s not man vs machine. It’s man plus machine. That’s the future.”

About Terra Security

Founded in 2024 by Shahar Peled and Gal Malachi, Terra offers an agentic-AI platform for continuous web application penetration testing. Enhanced by a human-in-the-loop mechanism, Terra’s dedicated, fine-tuned AI agents perform thousands of best-of-breed tests with unparalleled efficiency, accuracy and robust attack surface coverage. Through tailor-made attacks based on unique business context and risk profiles, Terra is revolutionizing the way enterprises build and run their pentest program. For more information, visit: https://www.terra.security.

Photo: https://mma.prnewswire.com/media/2669826/Terra_Security.jpg

Media contact:
Inbar Kneller
ReBlonde for Terra Security
[email protected] 

SOURCE Terra Security

Argentina-based agricultural technology company specializing in biological solutions for regenerative agriculture to expand into new markets, fueled by new capital infusion

BUENOS AIRES, Argentina, April 22, 2025 — Today Puna Bio announced that it had closed a new round of founding led by Corteva, Inc., through its Corteva Catalyst platform.

The investment from one of the world´s leading agricultural technology companies, and other investors, will support the further development of Puna Bio’s product portfolio based on extremophile organisms.

Unlike traditional pesticides and fertilizers, Puna Bio’s innovative products are based on natural solutions that enhance nutrient uptake, tolerance to stress and crop quality. Their biological (non-GMO) seed treatments are based on the unique capabilities of extremophiles isolated from the highest and driest desert on Earth, La Puna of Argentina.

“Our solution, based on ancient bacteria dating back 3.5 billion years, maximizes productivity by 10 to 15 percent in fertile soils and revitalizes degraded soils that would normally be too acidic or salinized to be productive,” explains Franco Martínez Levis, Puna Bio’s CEO and co-founder. “With so much of the world’s agricultural land on the path to degradation and weather patterns becoming more extreme worldwide, our discovery platform ensures that we can continue feeding the global population in a sustainable way”

Puna Bio received its initial funding in 2022, led by At One Ventures, a US venture firm with deep roots in Silicon Valley. The capital enabled the establishment of the company’s first laboratory and growth of its core team.

The new round of funding led by Corteva, Inc., a global pure-play S&P 500 agriculture company [NYSE: CTVA], as well as participation from existing investors At One Ventures, SP Ventures, SOSV, Builders VC, and joined by new investor Dalus Capital.

“With its focus on new, more sustainable ways to enhance productivity, we see significant potential in Puna Bio and its technology,” said Tom Greene, senior director at Corteva and global leader for Corteva Catalyst. “We remain encouraged not only by Puna Bio’s unique approach to developing biological inputs, but by strong field results with new technology that presents an opportunity to enhance farmer profitability while promoting soil health and environmental sustainability.”

The new investment will enable Puna Bio to focus on deeper innovation and the development of new products. Additionally, the company will expand its business to the United States, Brazil, and Paraguay, where it has already made progress in regulatory approvals and commercialization.

About Puna Bio

Puna Bio is advancing agricultural resilience by harnessing extremophiles. Their innovative biological inputs help farmers boost yields, reduce fertilizer use, and grow crops on degraded soils.

With operations across   USA, Brazil, Paraguay, and Argentina, their two current commercial products—Kunza (for soybeans, cotton, and beans) and Kanzama (for wheat and barley)—have already been deployed on over 800,000 acres in just three commercial seasons. Through strategic partnerships and relentless innovation, Puna Bio is shaping a more sustainable future for global agriculture.

For more information, please visit www.puna.bio or contact us at [email protected]

SOURCE Puna Bio

– TGM-010 is a naturally occurring, fully-human neuroprotective antibody, with demonstrated ability to cross the BBB, internalize specifically into neurons and engage key stress management machinery to reduce neurological disability

– Financing allows GenrAb to emerge from stealth mode and aggressively push lead therapy into the clinic

– Growing pipeline of novel partnerable neurotherapeutic antibodies

DALLAS, April 22, 2025 – GenrAb, Inc., a developer of first-in-class neuroprotective therapies, today announced completion of a private placement with aggregate gross proceeds of $5.6 million dollars (the “Seed Financing“). The Company will use the proceeds from this Seed Financing to accelerate the development of its lead candidate, TGM-010, a novel, fully-human, neuroprotective antibody which is the first in a growing pipeline of novel neurotherapeutic antibodies selected for their potential to become high impact medicines.

GenrAb is optimizing the world’s most effective biological therapy creation engine, the human adaptive immune system. Employing proprietary immunogenetic models to search the cerebrospinal fluid (CSF) of patients undergoing active neurological disease, GenrAb has identified novel, neuronally-specific and neuroprotective antibodies. This is evident from GenrAb’s lead antibody therapy, TGM-010, which has repeatedly and independently demonstrated the capability to cross the blood-brain barrier (BBB), internalize specifically into neurons and engage key stress management machinery to reduce disability. This financing enables GenrAb to aggressively advance TGM-010 through IND and towards human clinical studies in 2026.

“We believe GenrAb has an unprecedented opportunity to develop a novel class of antibody therapeutics that protect neurons under stress.” said GenrAb’s Chief Executive Officer Larry Tiffany. “TGM-010 continues to validate our unique approach that unlocks naturally occurring human antibodies involved in reducing neurodegeneration and maintaining neuronal health. This financing is a key milestone in bringing our first-in-class neuroprotective antibody therapies to the clinic. We’re honored that our investment partners enthusiastically share our vision to seismically disrupt the worldwide neurological treatment market that remains significantly underserved given the number of neurodegenerative diseases for which no effective treatments are available.”

GenrAb is an emerging leader in the growing life sciences ecosystem of North Texas, having won multiple awards for its unique approach to treating neurodegeneration. The Company was founded on technology exclusively licensed from the UT Southwestern Medical Center, and is headquartered in BioLabs at Pegasus Park, Dallas. 

“Actium is pleased to have led this capital raise during a period of extreme market volatility,” said Jun Il Kwun, Managing Director of the Actium Group. “The strong demand for investment in GenrAb, after deep diligence by our team and others, resulted in a sophisticated and diverse syndicate including Salem Partners, GPG Ventures, Research Bridge Partners and Maytal Capital. This financing is a vote of confidence in the novel biology driving GenrAb’s innovative and disruptive technology, which has the potential to transform the treatment of CNS disorders to the great benefit of society.” 

About GenrAb, Inc.

GenrAb, Inc. is harnessing the power of adaptive human immunity to discover neuroprotective and neurotherapeutic human antibodies. Guided by proprietary immunogenetic models, the Company interrogates the cerebrospinal fluid in patients with active neurological disease to harvest novel human disease associated antibodies. Antibodies such as TGM-010, are selected based on their antineuronal capabilities and potential for managing neuronal stress to preserve cell function and survival. Using this unique approach, GenrAb is building a pipeline of patented therapeutic antibodies that can durably reduce disability in patients suffering from neurodegenerative disease, democratizing the availability of even rare antibodies found only in certain patients with neurological disease. GenrAb has been the recipient of multiple accolades, recently featured in the Dallas Morning News, as the North Texas Therapeutics Innovator of the Year, a Texas Biotech Rising Star while winning multiple Golden Ticket awards in highly competitive environments that were sponsored by Boehringer-Ingelheim (’23), and Otsuka Pharmaceuticals (’24).

For more information on the Company please see www.genrab.com

About Actium Group

Actium Group is an investment firm founded in 2009 in Seoul, Korea, with headquarters in Dallas, Texas. Actium partners with the most promising life science and technology companies in North America, Europe, and Asia, providing multi-stage capital and managerial support through realization. 

For more information on Actium, please see www.actiuminvest.com 

Contact Information for Investors and Business Development:

Larry Tiffany
[email protected] 

SOURCE GenrAb

The facility will be capable of processing 6 million end-of-life solar PV modules by 2030, producing high-grade critical materials such as silicon, aluminum, copper, and silver.

JACKSONVILLE, Fla., April 22, 2025 —OnePlanet Solar Recycling, LLC (“OnePlanet”), an advanced materials recovery processor specializing in end-of-life solar panels, today announced the successful close of a $7 million seed financing round to advance development of its $90M industrial-scale ‘River City’ Project, a first-of-its-kind solar panel recycling facility located in Green Cove Springs, Florida.

This initial phase of capital will support final engineering, permitting, and pre-construction activities for the facility, which is designed to process over 2 million end-of-life photovoltaic (PV) modules annually upon commissioning in 2027, with planned expansions for additional phases totaling 6 million modules by 2030. The facility is expected to be one of the largest dedicated solar recycling operations in North America and represents a strategic response to the accelerating wave of solar decommissioning anticipated over the coming decades.

The financing round was led by Khasma Capital, an investment fund focused on the circular economy and emerging energy transition assets. Khasma’s investment reflects growing institutional recognition that solar recycling is not a strictly downstream issue, but a critical upstream opportunity essential to sustaining U.S. clean energy buildout at scale.

“OnePlanet has assembled a team with both deep technical expertise and a disciplined approach to infrastructure project execution,” said Ashlynn Horras, Partner at Khasma Capital. “This investment reflects our belief that solar module recycling is not only necessary – it is investable at scale, with durable tailwinds driven by regulation, economics, and resource security.”

In parallel with the equity raise, OnePlanet’s River City project was awarded a $14.5 million Investment Tax Credit under the Department of Energy’s competitive Section 48C(e) Advanced Energy Project Program, established by the Inflation Reduction Act. The tax credit specifically supports domestic advanced manufacturing facilities that recover and reintroduce critical materials—such as silicon, aluminum, and copper—back into U.S. supply chains.

“The River City Project is purpose-built infrastructure for a new era of clean energy maturity,” said André Pujadas, Chief Executive Officer of OnePlanet. “Solar as an industry is now at an inflection point in its lifecycle, where we can’t simply install megawatts—we must also build the industrial capacity to recover and reintegrate the very materials that enable it. This facility will be a cornerstone of that effort.”

Before founding OnePlanet, CEO André Pujadas held senior roles at the largest steel producers in the world including Nucor Corporation and Severstal and was directly involved in the industrial and technological shift that not only revolutionized global crude steel production, but transformed scrap metal from a low-value end-of-life product into a highly sought ferrous commodity. At the heart of the massive sustainable steel market was the deployment of Electric Arc Furnace (EAF) technology. During his tenure at Nucor, Pujadas was directly involved in advancing and implementing EAF-based operations. That not only revolutionized domestic steelmaking, but also redefined how the U.S. approached industrial recycling at scale. Today, Pujadas sees the solar industry at a similar inflection point.

“With millions of panels slated for decommissioning, the opportunity to recover high-purity silicon—and reintroduce it as a captive, domestic feedstock—parallels the EAF-era transformation we pioneered at Nucor,” said Pujadas. “OnePlanet is building the infrastructure to harness this untapped materials stream as a foundational input not only for clean energy manufacturing, but also for the U.S. semiconductor industry—supporting domestic chip production and fortifying critical supply chains for decades to come.”

The River City project is being developed as a scalable, platform-level operating asset for a national network of facilities, supporting the buildout of a domestic closed-loop solar economy. The plant’s proprietary state-of-the-art fully automated separation and recovery technologies are optimized for throughput, and recovery of high purity streams strategically positioning OnePlanet as a foundational player in the future of energy-critical minerals recovery in the U.S.

The OnePlanet founding team brings deep institutional expertise spanning global finance, heavy industry, and clean energy infrastructure, with alumni from industry leaders such as Nucor, Goldman Sachs, Commercial Metals Company, and PineGate Renewables. This breadth of experience positions OnePlanet at the nexus of metals manufacturing, advanced materials recovery at industrial scale, and renewable energy asset management. The team was recently strengthened by two key hires—one with a background in advanced chemical production processes at 3M, Koch Industries, and Dow Chemical, and another with utility-scale sales experience at leading renewable energy OEMs including Trina Solar, Array Technologies, and Power Electronics.

About OnePlanet Solar Recycling, LLC

Founded in 2023, OnePlanet is a U.S.-based advanced materials recovery company developing large-scale, end-to-end solutions for solar asset owners. Headquartered in Jacksonville, Florida, OnePlanet is building the infrastructure needed to keep millions of solar panels out of landfills—and putting valuable materials back into American supply chains. We are fully dedicated and committed in our resolve to supporting a true circular economy, whereby both production and consumption aspires to use and reuse materials, as many times as possible.

Learn more at www.1planetrecycling.com

Media Contact
[email protected]
OnePlanet Solar Recycling, LLC
Jacksonville, FL

SOURCE OnePlanet Solar Recycling

This round brings Manychat’s total funding to $163.3 million, powering global expansion, R&D, and advanced AI-agent innovation

PALO ALTO, Calif., April 22, 2025 — Manychat, a global leader in conversational AI and automation across social and messaging platforms, today announced a $140 million growth capital raise led by Summit Partners. This brings Manychat’s total funding to $163.3 million since its founding in 2015, including its first institutional investment of $18 million in 2019 by Bessemer Venture Partners.

Social platforms are the new arena of global commerce, with socially driven commerce projected to surpass $100 billion in the U.S. alone by 2026. Manychat sits at the center of this shift, helping creators and businesses leverage AI and automation to forge stronger and more impactful relationships with their audiences.

Manychat powers billions of messages annually on Instagram, TikTok, WhatsApp, Facebook Messenger, and other platforms, helping more than a million businesses in 170+ countries automate customer interactions, maximize engagement, and unlock monetization potential.

“Manychat was founded with a mission to help businesses grow by building meaningful customer relationships,” said Mike Yan, co-founder and CEO at Manychat. “We also take pride in our ability to package and simplify new foundational technologies for the benefit of our customers. The more useful and effective our technology becomes, the more our customers can focus on delivering exceptional value in their space. This new funding, along with Summit Partners’ guidance and expertise, will support our continued innovation in the realm of agentic AI and intelligent automation, helping our team and our products deliver true value for businesses and creators around the world.”

Manychat, already a profitable company, will use this funding to accelerate its global expansion, invest further in R&D, enhance marketing and customer support capabilities, and advance breakthrough AI-Agent features across new and existing channels. In 2024, the company introduced Manychat AI, which is already used by tens of thousands of creators and businesses to better scale conversations with their customers.

“We believe the rapid growth in social commerce is driving a critical need for brands to invest in strategies and solutions that help build and sustain customer engagement across social and messaging platforms,” said Sophia Popova, Partner at Summit Partners who has joined the Manychat Board of Directors. “Manychat’s innovative platform is helping to redefine how businesses and creators engage with their audiences and to set new standards in digital communication and marketing. We are excited to partner with the Manychat team to help accelerate their global expansion and further enhance their AI-driven solutions.”

About Manychat
Founded in 2015 by Mike Yan and Antony Gorin, Manychat is a global leader in conversational AI and automation across social and messaging platforms, helping businesses and creators engage their audiences through intelligent, automated conversations. With over a million users in 170 countries, Manychat powers billions of conversations optimized for driving engagement, nurturing relationships, and maximizing monetization potential across platforms like Instagram, TikTok, WhatsApp, and Messenger.

Follow Manychat at: manychat.com  |  IG: @manychat

Media contact:

Rebecca Reese
[email protected]
(603) 305-4155

About Summit
Summit Partners is a leading growth-focused investment firm. Summit invests across growth sectors of the economy and, since the firm’s founding in 1984, has invested in more than 550 companies in technology, healthcare and other growth industries. These companies have completed more than 175 public equity offerings, and more than 250 have been acquired through strategic mergers and sales. Summit maintains offices in North America and Europe and seeks to invest in category-leading, profitable growth companies worldwide. For more information, please see www.summitpartners.com or follow on LinkedIn.

Media Contact:
Susan Barr
[email protected]

SOURCE Manychat

CARDIFF-BY-THE-SEA, Calif., April 22, 2025 — Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of $40 million in Series A financing. The round includes $20 million in new capital and the conversion of $20 million in seed-round debt. Participants include several leading strategics, venture capital firms and family offices, with multiple seed investors reinvesting – underscoring strong confidence in the company’s initial focus on ventricular tachycardia (VT) and the broader versatility of its technology.

The funding will support the completion of two pilot studies – VCAS for VT and Field PULSE for atrial fibrillation (AF) – as well as continued development of Field’s commercial PFA system and operational scale-up in preparation for VERITAS, the company’s pivotal trial focused on VT.

“This financing is a pivotal milestone as we advance in redefining how electrophysiologists approach ablation therapy,” said Steven Mickelsen, M.D., founder and chief executive officer of Field Medical. “With the support of our investors, we are accelerating the development of the FieldForce™ Ablation System, building on early clinical evidence, and moving closer to our commercial goal of expanding access to next-generation PFA solutions for cardiac ablation.”

“We are encouraged by the strong support and confidence from both new investors and our reinvesting seed-round investor base,” said Oskar Dadason, chief financial officer. “This funding enables us to execute our strategic plan with speed and focus as we transition from early-stage innovation into commercial readiness.”

Field Medical is developing transformative technology for the treatment of all cardiac arrhythmias, including VT and AF. The FieldForce Ablation System, featuring the first built-for-purpose, contact force focal PFA catheter, enables an instantaneous ablation workflow, with therapy delivered in a fraction of a second. Recent results from the VCAS (VT) and PULSE (AF) pilot studies demonstrate the system’s versatility. Powered by FieldBending™, the company’s proprietary technology that delivers brief, high-intensity electric fields, the System is positioned as the single, advanced solution for treating a full spectrum of cardiac arrhythmias.

About Field Medical^® Inc.
Founded in 2022, Field Medical is advancing next-generation pulsed field ablation (PFA) technologies to address the complex needs of modern cardiac ablation. The company is led by Dr. Steven Mickelsen, a pioneer in pulsed electric field technology and a leading innovator in the field. His foundational work in PFA established the basis for modern advancements in the technology, which Field Medical continues to refine with its groundbreaking solutions. In 2024, Field Medical’s technology was recognized by the FDA with Breakthrough Device Designation and inclusion in the TAP Pilot Program. 

For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn and X.

The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use.

The Growing Prevalence of VT and AF
Ventricular tachycardia (VT) and atrial fibrillation (AF) are two of the most common and serious arrhythmias, contributing to stroke, heart failure, sudden cardiac death and escalating health care costs. VT and premature ventricular contractions (PVCs) affect more than 6 million people in the United States and Europe, while AF impacts an estimated 2% to 6% of the global population.

The AF catheter ablation market is currently valued at $5 billion and is projected to grow at a compound annual growth rate of 13% to 16%, surpassing $11 billion by 2034. In comparison, the global VT market— which includes devices and catheter ablation—was valued at approximately $12.5 billion in 2021 and is expected to grow at a compound annual growth rate of 5.26%, reaching $17 billion by 2027. Notably, the catheter ablation segment within the VT treatment market is projected to grow at a higher rate of 13% annually during this period, reflecting increased adoption of catheter-based interventions for VT management.

Media Contact
Holly Windler
619.929.1275

Logo – https://mma.prnewswire.com/media/2574173/Field_Medical_Logo_Block_WhiteOnBlack_Logo.jpg